Vimarsana
Biggest News Aggregation in the World

Page 27 - First North News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from First North. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In First North Today - Breaking & Trending Today

Faron Announces Release of Research Confirming Bexmarilimab Efficacy and Safety in MATINS Trial - Vimarsana News

Faron Announces Release of Research Confirming Bexmarilimab Efficacy and Safety in MATINS Trial

FINLAND - Faron Pharmaceuticals Oy , a clinical-stage biopharmaceutical company focused on tackling cancers via novel immunotherapies, today announces the release of further insights from its Phase... | April 25, 2023

Nasdaq Stockholm AB: Listing of subscription rights and paid subscription units of Midsummer AB (230/23) - Vimarsana News

Nasdaq Stockholm AB: Listing of subscription rights and paid subscription units of Midsummer AB (230/23)

With effect from April 26, 2023, the subscription rights in Midsummer AB will be traded on the list for First North Growth Market. Trading will continue up until and including May 05, 2023. Instrument:

Montana BidCo Oy supplements the offer document relating to the public cash offer to the shareholders of Nordic Lights Group Corporation - Vimarsana News

Montana BidCo Oy supplements the offer document relating to the public cash offer to the shareholders of Nordic Lights Group Corporation

24.4.2023 10:15:01 EEST | Nordic Lights Group Oyj | Company Announcement Montana BidCo Oy supplements the offer document relating to the public cash offer to the shareholders of Nordic Lights... | April 24, 2023

Reminder: Integre Trans UAB bond public offer auction - Vimarsana News

Reminder: Integre Trans UAB bond public offer auction

From April 12, 2023, 09:00 EET Integre Trans UAB bonds (ISIN code LT0000407553) public offer subscription process is launched. The Subscription process closing date is April 28, 2023, 15:30 EET. Up to

Investegate |Faron Pharma. Oy Announcements | Faron Pharma. Oy: Bexmarilimab Efficacy and Safety in MATINS Trial - Vimarsana News

Investegate |Faron Pharma. Oy Announcements | Faron Pharma. Oy: Bexmarilimab Efficacy and Safety in MATINS Trial

Investegate announcements from Faron Pharma. Oy, Bexmarilimab Efficacy and Safety in MATINS Trial